| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |